Mechanisms of persistence by small DNA tumor viruses

Curr Opin Virol. 2018 Oct:32:71-79. doi: 10.1016/j.coviro.2018.09.002. Epub 2018 Oct 1.

Abstract

Virus infection contributes to nearly 15% of human cancers worldwide. Many of the oncogenic viruses tend to cause cancer in immunosuppressed individuals, but maintain asymptomatic, persistent infection for decades in the general population. In this review, we discuss the tactics employed by two small DNA tumor viruses, Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV), to establish persistent infection. We will also highlight recent key findings as well as outstanding questions regarding the mechanisms by which HPV and MCPyV evade host immune control to promote their survival. Since persistent infection enables virus-induced tumorigenesis, identifying the mechanisms by which small DNA tumor viruses achieve latent infection may inform new approaches for preventing and treating their respective human cancers.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Carcinogenesis*
  • Carcinoma, Merkel Cell / virology
  • Host Microbial Interactions
  • Humans
  • Immune Evasion
  • Immunocompromised Host
  • Merkel cell polyomavirus / immunology
  • Merkel cell polyomavirus / physiology*
  • Papillomaviridae / immunology
  • Papillomaviridae / physiology*
  • Tumor Virus Infections / virology*
  • Virus Latency / immunology